Neurovascular Thrombus Management Market Size, Share & Trends Analysis | Global | 2023-2029 | MedSuite | Includes: Stent Retrievers and Aspiration Catheters
- Year: 2023
- Scope: 10 Years
- Region: Global
- Pages: 44
- Published Date: 03/21/2023
- Type: MedCore
Overall, the global neurovascular thrombus management market was valued at $1.3 billion in 2022. This is expected to increase over the forecast period at a CAGR of 5.9% to reach $1.9 billion.
The full report suite on the global neurovascular thrombus management market includes stent retrievers and aspiration catheters.
MARKET REPORT DATA TYPES INCLUDED
- Unit Sales, Average Selling Prices, Market Size & Growth Trends
- COVID-19 Impact Analysis
- Market Drivers & Limiters
- Market Forecasts Until 2029, and Historical Data to 2019
- Recent Mergers & Acquisitions
- Company Profiles and Product Portfolios
- Leading Competitors
GLOBAL NEUROVASCULAR THROMBUS MANAGEMENT MARKET INSIGHTS
One of the main global neurovascular thrombus management market drivers is an improvement in technology. There have been significant improvements in mechanical thrombus management devices, which has continued to improve clinical outcomes. This will drive increased procedural growth as well. On the other hand, one of the main market limiters is that there is a limited time frame within which mechanical thrombectomy treatment needs to be deployed.
GLOBAL NEUROVASCULAR THROMBUS MANAGEMENT MARKET SHARE INSIGHTS
Within the global market for neurovascular thrombus management, there are three key market players – Medtronic, Stryker, and Penumbra.
In 2022, Medtronic was the leader in the global neurovascular thrombus management market. The company competes with its SolitaireTMFlow Restoration Device.
MARKET SEGMENTATION SUMMARY
- Global Stent Retrievers Market
- Global Aspiration Catheter Market
RESEARCH SCOPE SUMMARY
| Report Attribute | Details |
|---|---|
| Regions | North America (Canada, United States) Latin America (Argentina, Brazil, Chile, Colombia, Mexico, Peru, Venezuela) Western Europe (Austria, Benelux, France, Germany, Italy, Portugal, Scandinavia, Spain, Switzerland, U.K.) Central & Eastern Europe (Baltic States, Bulgaria, Croatia, Czech Republic, Greece, Hungary, Kazakhstan, Poland, Romania, Russia, Turkey, Ukraine) Middle East (Bahrain, Iran, Israel, Kuwait, Oman, Qatar, Saudi Arabia, United Arab Emirates) Asia Pacific (Australia, Cambodia, China, Hong Kong, India, Indonesia, Japan, Malaysia, Myanmar, New Zealand, Philippines, Singapore, South Korea, Taiwan, Thailand, Vietnam) Africa (Algeria, Egypt, Ghana, Kenya, Libya, Morocco, Nigeria, South Africa, Sudan, Uganda) |
| Base Year | 2022 |
| Forecast | 2023-2029 |
| Historical Data | 2019-2022 |
| Quantitative Coverage | Market Size, Market Shares, Market Forecasts, Market Growth Rates, Units Sold, and Average Selling Prices. |
| Qualitative Coverage | COVID19 Impact, Market Growth Trends, Market Limiters, Competitive Analysis & SWOT for Top Competitors, Mergers & Acquisitions, Company Profiles, Product Portfolios, FDA Recalls, Disruptive Technologies, Disease Overviews. |
| Data Sources | Primary Interviews with Industry Leaders, Government Physician Data, Regulatory Data, Hospital Private Data, Import & Export Data, iData Research Internal Database. |
WHY CHOOSE IDATA?
- Experts Only – iData has been around for over 17 years and is the trusted source of intelligence, and data-driven insights for key industry players. We are made up of specialists with a sole focus on medical devices, dental devices and pharmaceuticals. Our research and consulting field of endeavour never strays from the medical device industry and, because of this, we are the number one choice for leading companies in this field.
- Global Coverage – iData’s unique methodology, and its expansion to over 70 countries world-wide, has made it one of the most viable sources of intelligence for global companies along with those who plan to expand their portfolio beyond the confines of their own country. Providing procedural data at the country level is another testimony to the trusted global coverage we provide.
- Attention to Detail – It’s our attention to small details, scheduling of timelines, and keen project management that makes us stand out from the rest. We are creative, and our reports include metrics such as procedure numbers, ASPs, and SKU-level insights that are not found elsewhere.
- Pricing – When comparing like-with-like, iData’s prices are not only extremely competitive but also the most cost-effective. We strive for success and want the same for our clients. With the level of detail incorporated into each report alongside the extensive segmentation provided, no other report compares at our price point.
Table of Contents
| Neurovascular thrombus Management Market |
| 13.1 Executive Summary |
| 13.1.1 Global Neurovascular Thrombus Management Market Overview |
| 13.1.2 Competitive Analysis |
| 13.1.3 Markets Included |
| 13.1.4 Regions Included |
| 13.2 Introduction |
| 13.3 Procedure Numbers |
| 13.4 Market Overview |
| 13.4.1 By Segment |
| 13.4.2 By Region |
| 13.5 Market Analysis and Forecast |
| 13.5.1 Total Neurovascular Thrombus Management Market |
| 13.5.2 Stent Retriever Market |
| 13.5.3 Aspiration Catheter Market |
| 13.6 Drivers and Limiters |
| 13.6.1 Market Drivers |
| 13.6.2 Market Limiters |
| 13.7 Competitive Market Share Analysis |
Companies Included:
| Medtronic |
| Stryker |
| Penumbra |
| Phenox |
| Cerenovus |
| Imperative Care |
| MicroVention |
| Rapid Medical |
| Others include: Acandis, Balt, BTG, Insera Therapeutics, MIVI Neuroscience, etc. |
List of Charts
| Chart 13‑1: Neurovascular Thrombus Management Market, Global, 2022 & 2029 |
| Chart 13‑2: Neurovascular Thrombus Management Procedures, Global, 2022 |
| Chart 13‑3: Neurovascular Thrombus Management Procedures by Region, Global, 2019 – 2029 |
| Chart 13‑4: Neurovascular Thrombus Management Market by Region, Global, 2019 – 2029 |
| Chart 13‑5: Leading Competitors, Neurovascular Thrombus Management Market, Global, 2022 |
List of Figures
| Figure 13‑1: Neurovascular Thrombus Management Markets Covered |
| Figure 13‑2: Neurovascular Thrombus Management Regions Covered, Global (1 of 2) |
| Figure 13‑3: Neurovascular Thrombus Management Regions Covered, Global (2 of 2) |
| Figure 13‑4: Neurovascular Thrombus Management Procedures by Segment, Global, 2019 – 2029 |
| Figure 13‑5: Neurovascular Thrombus Management Procedures by Region, Global, 2019 – 2029 |
| Figure 13‑6: Neurovascular Thrombus Management Procedures by Country, North America, 2019 – 2029 |
| Figure 13‑7: Neurovascular Thrombus Management Procedures by Country, Latin America, 2019 – 2029 (1 of 2) |
| Figure 13‑8: Neurovascular Thrombus Management Procedures by Country, Latin America, 2019 – 2029 (2 of 2) |
| Figure 13‑9: Neurovascular Thrombus Management Procedures by Country, Western Europe, 2019 – 2029 |
| Figure 13‑10: Neurovascular Thrombus Management Procedures by Country, Central & Eastern Europe, 2019 – 2029 (1 of 2) |
| Figure 13‑11: Neurovascular Thrombus Management Procedures by Country, Central & Eastern Europe, 2019 – 2029 (2 of 2) |
| Figure 13‑12: Neurovascular Thrombus Management Procedures by Country, Middle East, 2019 – 2029 |
| Figure 13‑13: Neurovascular Thrombus Management Procedures by Country, Asia-Pacific, 2019 – 2029 (1 of 3) |
| Figure 13‑14: Neurovascular Thrombus Management Procedures by Country, Asia-Pacific, 2019 – 2029 (2 of 3) |
| Figure 13‑15: Neurovascular Thrombus Management Procedures by Country, Asia-Pacific, 2019 – 2029 (3 of 3) |
| Figure 13‑16: Neurovascular Thrombus Management Procedures by Country, Africa, 2019 – 2029 |
| Figure 13‑17: Neurovascular Thrombus Management Market by Segment, Global, 2019 – 2029 (US$M) |
| Figure 13‑18: Neurovascular Thrombus Management Market by Region, Global, 2019 – 2029 (US$M) |
| Figure 13‑19: Neurovascular Thrombus Management Market, Global, 2019 – 2029 |
| Figure 13‑20: Units Sold by Region, Neurovascular Thrombus Management Market, Global, 2019 – 2029 |
| Figure 13‑21: Average Selling Price by Region, Neurovascular Thrombus Management Market, Global, 2019 – 2029 (US$) |
| Figure 13‑22: Market Value by Region, Neurovascular Thrombus Management Market, Global, 2019 – 2029 (US$M) |
| Figure 13‑23: Stent Retriever Market, Global, 2019 – 2029 |
| Figure 13‑24: Units Sold by Region, Stent Retriever Market, Global, 2019 – 2029 |
| Figure 13‑25: Average Selling Price by Region, Stent Retriever Market, Global, 2019 – 2029 (US$) |
| Figure 13‑26: Market Value by Region, Stent Retriever Market, Global, 2019 – 2029 (US$M) |
| Figure 13‑27: Aspiration Catheter Market, Global, 2019 – 2029 |
| Figure 13‑28: Units Sold by Region, Aspiration Catheter Market, Global, 2019 – 2029 |
| Figure 13‑29: Average Selling Price by Region, Aspiration Catheter Market, Global, 2019 – 2029 (US$) |
| Figure 13‑30: Market Value by Region, Aspiration Catheter Market, Global, 2019 – 2029 (US$M) |
| Figure 13‑31: Leading Competitors, Neurovascular Thrombus Management Market, Global, 2022 |
iData’s 9-Step Research Methodology
Our reports follow an in-depth 9-step methodology which focuses on the following research systems:- Original primary research that consists of the most up-to-date market data
- Strong foundation of quantitative and qualitative research
- Focused on the needs and strategic challenges of the industry participants
Step 1: Project Initiation & Team Selection During this preliminary investigation, all staff members involved in the industry discusses the topic in detail.
Step 2: Prepare Data Systems and Perform Secondary Research The first task of the research team is to prepare for the data collection process: Filing systems and relational databases are developed as needed.
Step 3: Preparation for Interviews & Questionnaire Design The core of all iData research reports is primary market research. Interviews with industry insiders represent the single most reliable way to obtain accurate, current data about market conditions, trends, threats and opportunities.
Step 4: Performing Primary Research At this stage, interviews are performed using contacts and information acquired in the secondary research phase.
Step 5: Research Analysis: Establishing Baseline Estimates Following the completion of the primary research phase, the collected information must be synthesized into an accurate view of the market status. The most important question is the current state of the market.
Step 6: Market Forecast and Analysis iData Research uses a proprietary method to combine statistical data and opinions of industry experts to forecast future market values.
Step 7: Identify Strategic Opportunities iData analysts identify in broad terms why some companies are gaining or losing share within a given market segment.
Step 8: Final Review and Market Release An integral part of the iData research methodology is a built-in philosophy of quality control and continuing improvement is integral to the iData philosophy.
Step 9: Customer Feedback and Market Monitoring iData philosophy of continuous improvement requires that reports and consulting projects be monitored after release for customer feedback and market accuracy.
Explore Options
| Report Summary | FREE |
Neurovascular Thrombus Management Market Size, Share & Trends Analysis | Global | 2023-2029 | MedSuite | Includes: Stent Retrievers and Aspiration Catheters
$4,995 – $9,995
The full report suite on the global neurovascular thrombus management market includes stent retrievers and aspiration catheters.
- 2023
- 10 Years
- Global
- 03/21/2023
- 44
- MedCore
Related Reports
